NO20016093L - Kloning og ekspresjon av en ny 5-HT4-receptor - Google Patents

Kloning og ekspresjon av en ny 5-HT4-receptor

Info

Publication number: NO20016093L
Authority: NO; Norway
Prior art keywords: cloning; receptor; expression; novel
Prior art date: 1999-06-14

Application number

NO20016093A

Other languages

English (en)

Norwegian (no)

Other versions

NO20016093D0 (no

Inventor

Eckhard Bender

Armelle Nathalie Franco Pindon

Irma Petronella Van Oers

Mirek Jurzak

Walter Herman Maria Lou Luyten

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-14

Filing date

2001-12-13

Publication date

2002-01-28

2001-12-13 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2001-12-13 Publication of NO20016093D0 publication Critical patent/NO20016093D0/no

2002-01-28 Publication of NO20016093L publication Critical patent/NO20016093L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Neurology (AREA)
Pulmonology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Toxicology (AREA)
Immunology (AREA)
Wood Science & Technology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Dermatology (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO20016093A 1999-06-14 2001-12-13 Kloning og ekspresjon av en ny 5-HT4-receptor NO20016093L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9913850.5A GB9913850D0 (en)	1999-06-14	1999-06-14	Cloning and expression of a novel receptor
PCT/EP2000/005592 WO2000077199A1 (fr)	1999-06-14	2000-06-14	Clonage et expression d'un nouveau recepteur 5-ht4

Publications (2)

Publication Number	Publication Date
NO20016093D0 NO20016093D0 (no)	2001-12-13
NO20016093L true NO20016093L (no)	2002-01-28

Family

ID=10855345

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20016093A NO20016093L (no)	1999-06-14	2001-12-13	Kloning og ekspresjon av en ny 5-HT4-receptor

Country Status (12)

Country	Link
US (1)	US6998244B1 (fr)
EP (1)	EP1190057A1 (fr)
JP (1)	JP2003502040A (fr)
KR (1)	KR100689871B1 (fr)
AU (1)	AU778107B2 (fr)
CA (1)	CA2376389A1 (fr)
GB (1)	GB9913850D0 (fr)
IL (1)	IL147051A0 (fr)
NO (1)	NO20016093L (fr)
NZ (1)	NZ515479A (fr)
WO (1)	WO2000077199A1 (fr)
ZA (1)	ZA200110273B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9913850D0 (en)	1999-06-14	1999-08-11	Janssen Pharmaceutica Nv	Cloning and expression of a novel receptor
WO2004009630A1 (fr) *	2002-07-22	2004-01-29	Bayer Healthcare Ag	Regulation du recepteur de la serotonine humaine
FR2846559B1 (fr) *	2002-10-31	2007-06-15	Centre Nat Rech Scient	Composition pharmaceutique pour la preparation d'un medicament destine a traiter et/ou a prevenir une pathologie liee a une conduite obsessionnelle
US20070128603A1 (en) *	2003-05-28	2007-06-07	Bayer Healthcare Ag	Diagnostic and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7)
US8084842B2 (en) *	2008-03-25	2011-12-27	Macronix International Co., Ltd.	Thermally stabilized electrode structure
CN103614382B (zh) *	2013-10-28	2016-04-13	浙江大学	菜青虫5-羟色胺受体基因Pr5-HT8及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5472866A (en) *	1992-12-24	1995-12-05	Synaptic Pharmaceutical Corporation	DNA encoding 5-HT4A serotonin receptors
GB9913850D0 (en)	1999-06-14	1999-08-11	Janssen Pharmaceutica Nv	Cloning and expression of a novel receptor

1999
- 1999-06-14 GB GBGB9913850.5A patent/GB9913850D0/en not_active Ceased
2000
- 2000-06-14 KR KR1020017014823A patent/KR100689871B1/ko not_active Expired - Fee Related
- 2000-06-14 WO PCT/EP2000/005592 patent/WO2000077199A1/fr not_active Ceased
- 2000-06-14 EP EP00947854A patent/EP1190057A1/fr not_active Withdrawn
- 2000-06-14 US US10/018,257 patent/US6998244B1/en not_active Expired - Fee Related
- 2000-06-14 JP JP2001503643A patent/JP2003502040A/ja not_active Withdrawn
- 2000-06-14 CA CA002376389A patent/CA2376389A1/fr not_active Abandoned
- 2000-06-14 IL IL14705100A patent/IL147051A0/xx unknown
- 2000-06-14 AU AU61507/00A patent/AU778107B2/en not_active Ceased
- 2000-06-14 NZ NZ515479A patent/NZ515479A/en unknown
2001
- 2001-12-13 ZA ZA200110273A patent/ZA200110273B/xx unknown
- 2001-12-13 NO NO20016093A patent/NO20016093L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
US6998244B1 (en)	2006-02-14
AU778107B2 (en)	2004-11-18
KR20010113052A (ko)	2001-12-24
KR100689871B1 (ko)	2007-03-09
EP1190057A1 (fr)	2002-03-27
WO2000077199A1 (fr)	2000-12-21
GB9913850D0 (en)	1999-08-11
CA2376389A1 (fr)	2000-12-21
AU6150700A (en)	2001-01-02
IL147051A0 (en)	2002-08-14
JP2003502040A (ja)	2003-01-21
NO20016093D0 (no)	2001-12-13
NZ515479A (en)	2003-11-28
ZA200110273B (en)	2003-05-28

Publication	Publication Date	Title
DK1233964T3 (da)	2005-09-19	Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
DK1394150T3 (da)	2011-03-21	4-phenylpyridinderivater og deres anvendelse som NK-1-receptorantagonister
NO20013393D0 (no)	2001-07-09	Brönnsementeringsfremgangsmåter og sammensetninger
ID30262A (id)	2001-11-15	Ligan reseptor melanokortin
NO994177D0 (no)	1999-08-27	Atropisomere av 3-aryl-4(3H)-kinazoloner og deres anvendelse som AMPA-reseptor-antagonister
NO20020023D0 (no)	2002-01-03	Utförelse og utpröving av brukerprogrammer
DK0975778T3 (da)	2007-10-08	Anvendelse af glyphostat-resistende majslinier
DK0869126T3 (da)	2002-11-18	Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
NO995852D0 (no)	1999-11-29	Ny form av S-omeprazol
DK1157005T3 (da)	2005-02-14	3-phenylpyridinderivater og anvendelsen deraf som NK-1-receptorantagonister
NO20001323D0 (no)	2000-03-14	Dipeptid-apoptose inhibitorer og deres anvendelse
NO20013887L (no)	2001-10-11	Sykliske substituerte sammensmeltede pyrrolokarbazoler og isoindoloner
ID24409A (id)	2000-07-20	Struktur suatu jembatan gitar
EP1015473A4 (fr)	2002-10-30	CLONAGE ET EXPRESSION DU RECEPTEUR DE betaAPP-C100 (C100-R)
NO20016093D0 (no)	2001-12-13	Kloning og ekspresjon av en ny 5-HT4-receptor
NO20016059D0 (no)	2001-12-12	Propagering av bölger gjennom materialer
DK1178981T3 (da)	2003-09-29	Substituerede 3-pyridyl-4-arylpyrroler og deres terapeutiske og profylaktiske anvendelser
ATE297084T1 (de)	2005-06-15	Synchronisierung von pcm und pseudozufallstaktgebern
NO20003128D0 (no)	2000-06-16	Nye p-aminofenylderivater og deres anvendelse
NO20014845D0 (no)	2001-10-05	Anvendelse av arylalkanoylpyridaziner
DK0869952T3 (da)	2002-01-21	Derivater af 5-naphthalen-1-yl-1,3-dioxaner, fremstilling og terapeutisk anvendelse heraf
DE60037197D1 (de)	2008-01-03	Verwendung funktioneller oraler präparate
GB9718808D0 (en)	1997-11-12	Cloning and expression of 5-HT receptor
FI104278B1 (fi)	1999-12-15	Parvekkeen tuentarakenne
NO995966D0 (no)	1999-12-03	5-naftalen-1-yl-1,3-dioksan-derivater, deres fremstilling og terapeutisk anvendelse

Legal Events

Date	Code	Title	Description
2009-02-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application